Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Rogaratinib |
Trade Name | |
Synonyms | BAY 1163877|BAY-1163877|BAY1163877 |
Drug Descriptions |
Rogaratinib (BAY 1163877) is a small molecule pan-FGFR inhibitor, which reduces downstream signaling, potentially resulting in decreased tumor cell proliferation (PMID: 27429073, PMID: 29451369, PMID: 30807645, PMID: 31405822). |
DrugClasses | FGFR Inhibitor (Pan) 26 |
CAS Registry Number | 1443530-05-9 |
NCIT ID | C112205 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Rogaratinib | Atezolizumab Rogaratinib | 1 | 1 |
Carboplatin + Paclitaxel + Rogaratinib | Carboplatin Paclitaxel Rogaratinib | 1 | 0 |
Copanlisib + Rogaratinib | Copanlisib Rogaratinib | 0 | 1 |
Crizotinib + Rogaratinib | Crizotinib Rogaratinib | 0 | 0 |
Docetaxel + Rogaratinib | Docetaxel Rogaratinib | 2 | 0 |
Fulvestrant + Palbociclib + Rogaratinib | Fulvestrant Palbociclib Rogaratinib | 0 | 1 |
Rogaratinib | Rogaratinib | 23 | 5 |